Publicationsback

Intra-Prostatic PRX302 Focal Therapy in Treating Clinically Significant Low-Intermediate Risk Prostate Cancer: An Open Label, Proof-of-Concept Study (PRX302-2-07 | PCa)

AUA 2017 PRX
View PDF »